Literature DB >> 27826882

Mandibular Advancement Appliance for Obstructive Sleep Apnea Treatment.

J Kostrzewa-Janicka1, P Śliwiński2, M Wojda3, D Rolski3, E Mierzwińska-Nastalska3.   

Abstract

A combination of abnormal anatomy and physiology of the upper airway can produce its repetitive narrowing during sleep, resulting in obstructive sleep apnea (OSA). Treatment of sleep-breathing disorder ranges from lifestyle modifications, upper airway surgery, continuous positive airway pressure (CPAP) to the use of oral appliances. A proper treatment selection should be preceded by thorough clinical and instrumental examinations. The type and number of specific oral appliances are still growing. The mandibular advancement appliance (MAA) is the most common type of a dental device in use today. The device makes the mandible protrude forward, preventing or minimizing the upper airway collapse during sleep. A significant variability in the patients' response to treatment has been observed, which can be explained by the severity of sleep apnea at baseline and duration of treatment. In some trials, patients with mild OSA show a similar treatment effect after the use of CPAP or MAA. It is worthwhile to give it a try with an oral appliance of MAA type in snoring, mild-to-moderate sleep apnea, and in individuals who are intolerant to CPAP treatment.

Entities:  

Keywords:  Airway collapse; Life style; Mandibular advancement device; Sleep apnea; Sleep disordered breathing; Treatment effectiveness; Upper airways

Mesh:

Year:  2017        PMID: 27826882     DOI: 10.1007/5584_2016_61

Source DB:  PubMed          Journal:  Adv Exp Med Biol        ISSN: 0065-2598            Impact factor:   2.622


  2 in total

1.  Patients with Obstructive Sleep Apnea Have Altered Levels of Four Cytokines Associated with Cardiovascular and Kidney Disease, but Near Normal Levels with Airways Therapy.

Authors:  Ye Wang; Richard B Meagher; Suresh Ambati; Huimin Cheng; Ping Ma; Bradley G Phillips
Journal:  Nat Sci Sleep       Date:  2021-03-25

2.  Patients with obstructive sleep apnea have suppressed levels of soluble cytokine receptors involved in neurodegenerative disease, but normal levels with airways therapy.

Authors:  Ye Wang; Richard B Meagher; Suresh Ambati; Ping Ma; Bradley G Phillips
Journal:  Sleep Breath       Date:  2020-10-09       Impact factor: 2.816

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.